Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment.

CONCLUSION: This study indicates what the widely accepted management strategies are. These strategies, and possibly others, should be assessed prospectively to ascertain effectiveness. The decision process is intricate and compatible with current venous thromboembolism guidelines.
PMID: 32173172 [PubMed - as supplied by publisher]

Source: European Journal of Internal Medicine - March 11, 2020 Category: Internal Medicine Authors: Leader A, Ten Cate V, Ten Cate-Hoek AJ, Beckers EAM, Spectre G, Giaccherini C, Gurevich-Shapiro A, Krashin E, Raanani P, Schouten HC, Falanga A, Ten Cate H Tags: Eur J Intern Med Source Type: research